The corporate aims to extend its investment decision in biotechnology and biosimilars, targeting an approximate current market price of USD 25 billion in India by 2025. Wockhardt's attempts to scale up producing capabilities are apparent, with designs to reinforce generation capability by thirty% in excess of the next two several https://bookmarksknot.com/story22015259/the-definitive-guide-to-codeine-syrup